PMID: 9546002Apr 18, 1998Paper

Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression

The American Journal of Psychiatry
R J VerkesG M Van Kempen

Abstract

Suicidal behavior has been associated with reduced central serotonergic function. Because selective serotonin reuptake inhibitors (SSRIs) enhance serotonergic function, the authors studied the efficacy of an SSRI, paroxetine, in the prevention of recurrent suicidal behavior. They conducted a 1-year double-blind study comparing paroxetine (40 mg/day) and placebo in 91 patients who had recently attempted suicide for at least a second time. None of the patients had experienced a major depressive episode or had any other major DSM-III-R axis I diagnoses. At least one cluster B personality disorder was present in 74 patients. With adjustment for the number of previous suicide attempts, paroxetine showed significant efficacy in the prevention of recurrent suicidal behavior. Among the patients who had attempted suicide fewer than five times, 12 (36%) in the placebo group (N = 33) and five (17%) in the paroxetine group (N = 30) made a subsequent suicide attempt. Paroxetine was also significantly more effective in patients who met fewer than 15 criteria for cluster B personality disorders than in those who met more than 15 criteria. Overall, paroxetine was not significantly different from placebo in its effect on depressive mood, hopele...Continue Reading

Citations

Nov 20, 2013·Journal of Pharmacology & Pharmacotherapeutics·Sathya PrakashRajesh Sagar
Aug 26, 2014·American Journal of Preventive Medicine·Joshua J GriffithsJ J Rasimas
May 1, 2001·Suicide & Life-threatening Behavior·A Roy
Mar 2, 2005·European Journal of Nuclear Medicine and Molecular Imaging·K PeremansR Dierckx
Jan 7, 2004·Biological Psychiatry·Philippe CourtetAlain Malafosse
Jan 27, 2005·Social Psychiatry and Psychiatric Epidemiology·Kirsi SuominenJouko Lönnqvist
Sep 20, 2011·International Review of Psychiatry·Joel Paris
Feb 9, 2007·Expert Review of Neurotherapeutics·Chi-Un Pae, Ashwin A Patkar
Nov 11, 2003·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Herman M Van Praag
Mar 22, 2003·Journal of the American Academy of Child and Adolescent Psychiatry·Madelyn S GouldDavid Shaffer
Dec 3, 2005·Child and Adolescent Psychiatric Clinics of North America·Joseph M Rey, Andrés Martin
Jan 13, 2005·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Marion LeboyerFrank Bellivier
Jun 19, 2013·Bipolar Disorders·Ghanshyam N Pandey
Apr 8, 2011·Suicide & Life-threatening Behavior·Shannon Wiltsey StirmanAaron T Beck
Jan 17, 2004·Journal of the American Academy of Child and Adolescent Psychiatry·Stanley J HueyJames Edwards
Sep 5, 2006·General Hospital Psychiatry·Kirsi Suominen, Jouko Lönnqvist
Aug 24, 2006·Journal of the American Academy of Child and Adolescent Psychiatry·Andrew C LeonSandro Galea
Oct 1, 2005·International Review of Psychiatry·Lukas PezawasSiegfried Kasper
Mar 29, 2003·Paediatric Drugs·Mirjami Pelkonen, Mauri Marttunen
Dec 3, 2013·Translational Neuroscience·Daniel C MathewsCarlos A Zarate
Feb 16, 2011·The International Journal of Neuropsychopharmacology·Luis H RipollLarry J Siever
Apr 17, 2010·Psychiatry Investigation·Youl-Ri Kim, Peter Tyrer
Jun 23, 2000·Biological Psychiatry·W Bligh-GloverC A Stockmeier
Dec 24, 2002·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Philippe CourtetAlain Malafosse
Jul 16, 2005·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Maria A OquendoJ John Mann
Feb 7, 2017·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Tony BensonBrendan Bunting
Sep 22, 2016·The Australian and New Zealand Journal of Psychiatry·Gregory CarterHelen Christensen
Mar 27, 2003·The Australian and New Zealand Journal of Psychiatry·David Martin ReithGreg Carter
Sep 15, 2010·Journal of Psychopharmacology·Xenia GondaZoltan Rihmer
Apr 12, 2003·Journal of Psychopharmacology·I M AndersonC M Bradshaw
Oct 4, 2007·Journal of the Royal Society of Medicine·Alexandra Pitman
Sep 25, 2003·The Journal of Nervous and Mental Disease·Netta HoreshAlan Apter
Feb 5, 2002·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Nina BacanerNadov Casuto
Aug 6, 2010·The Cochrane Database of Systematic Reviews·Najat KhalifaKlaus Lieb
Jul 7, 2015·The Cochrane Database of Systematic Reviews·Keith HawtonKees van Heeringen
Dec 1, 2001·Crisis·C van Heeringen
Apr 26, 2006·Alcoholism, Clinical and Experimental Research·Ulrich W PreussMichael Soyka
May 12, 2006·International Clinical Psychopharmacology·Lars SøndergårdLars V Kessing
Dec 2, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J John MannKaren D Wagner
Aug 23, 2008·European Archives of Psychiatry and Clinical Neuroscience·Hans-Jürgen MöllerUNKNOWN WPA Section on Pharmacopsychiatry
Sep 3, 2002·The British Journal of Psychiatry : the Journal of Mental Science·David OwensAllan House
Jun 18, 2010·The Cochrane Database of Systematic Reviews·Jutta StoffersKlaus Lieb
Nov 24, 2004·The Australian and New Zealand Journal of Psychiatry·UNKNOWN Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Deliberate Self-harm
Sep 25, 2019·Indian Journal of Psychological Medicine·Karthick NavinShivanand Kattimani
Sep 4, 2020·The Cochrane Database of Systematic Reviews·Najat R KhalifaLucy McCarthy
Oct 6, 2015·The Cochrane Database of Systematic Reviews·Keith HawtonKees van Heeringen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.